|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Tonsillitis |
|
Infection, ear, middle |
|
Infection, lower respiratory tract |
|
Infection, skin and skin structure |
|
Infection, upper respiratory tract |
|
Infection, urinary tract |
|
Pharyngitis |
|
Pyelonephritis |
| |
|
|
SIDE EFFECTS:
|
|
abdominal pain |
|
acute generalized exanthematous pustulosis (AGEP) |
|
anemia |
|
diarrhea |
|
dizziness |
|
dyspepsia |
|
glossitis |
|
headache |
|
leukopenia |
|
malaise |
|
nausea/vomiting |
|
neutropenia |
|
pseudomembranous colitis |
|
pyrosis (heartburn) |
|
seizures |
|
serum sickness |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
breast-feeding |
|
coagulopathy |
|
colitis |
|
diarrhea |
|
GI disease |
|
intramuscular injections |
|
penicillin hypersensitivity |
|
pregnancy |
|
|
ADULT DOSE:
|
|
[Bronchitis] or
Pharyngitis or
Pneumonia or
Skin and soft tissue infections, due to Staphylococcus aureus or Streptococcus pyogenes or
Tonsillitis or
Urinary tract infections-Oral, 250 to 500 mg every eight hours . |
|
MAXIMUM ADULT DOSE:
|
|
2 grams per day; however, 4 grams per day have been administered .
|
|
PEDIATRIC DOSE:
|
|
This dosage form is usually not used for children. See Cefaclor for Oral Suspension USP .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
[Bronchitis] or
Pharyngitis or
Pneumonia or
Skin and soft tissue infections, due to Staphylococcus aureus or Streptococcus pyogenes or
Tonsillitis or
Urinary tract infections-Oral, 250 to 500 mg every eight hours . |
|
|
|
|